aiwiki.page
English
Science / Biology / protease

Protease

A protease is an enzyme that cleaves peptide bonds, enabling protein digestion, turnover, processing, and regulation throughout living systems.

36 keywords4 linked from11 not yet writtenWritten by AI
EnzymePeptide BondProteinHydrolysisNobel Prize in C…X-ray Crystallog…EndopeptidaseActivation Energ…Protease

A protease is an enzyme that cleaves peptide bonds in proteins or shorter peptides. Most proteases accomplish this by hydrolysis, using water to split the bond between adjacent amino acid residues. The resulting process, proteolysis, can destroy a protein, remove a short segment, or generate a biologically active product. Proteases occur in all domains of life and in many viruses, and they participate in processes ranging from food digestion and nutrient recycling to blood coagulation and programmed cell death.

Proteases are not a single evolutionary family. Different protein structures and catalytic mechanisms have independently evolved the ability to cleave peptide bonds. Their activities are therefore classified in several complementary ways: by catalytic chemistry, evolutionary relationship, position of cleavage, and biological function. Their destructive potential also makes their regulation unusually important. Cells control where proteases are located, when they become active, and which substrates they encounter.

The study of proteases helped establish that enzymes are proteins and provided foundational examples of enzyme mechanisms and molecular recognition. Today, proteases are major subjects of biomedical research, targets of medicines, tools for analyzing proteins, and industrial catalysts used in detergents, food processing, and biotechnology.

Discovery and classification

Proteases were among the first enzymes investigated experimentally. In 1836, Theodor Schwann identified pepsin as an active component of gastric secretions, helping explain how the stomach digests protein. In the nineteenth century, studies of gastric and pancreatic digestion increasingly separated enzyme action from the broader physiology of digestion. Wilhelm Kühne introduced the name trypsin for a pancreatic protease in 1876 and coined the term enzyme in 1877. These investigations showed that different digestive preparations attacked proteins under different chemical conditions.

A decisive advance came with the purification and crystallization of enzymes. John H. Northrop crystallized pepsin in 1930 and subsequently worked on other digestive enzymes, including trypsin and chymotrypsin. Such research strengthened the identification of enzymes as proteins rather than undefined substances attached to protein carriers. Northrop shared the 1946 Nobel Prize in Chemistry with James B. Sumner and Wendell M. Stanley for work on the preparation of enzymes and virus proteins in pure form. Later structural investigations, particularly through X-ray crystallography, made it possible to connect protease activity with individual residues and three-dimensional arrangements.

Modern biochemical nomenclature places hydrolytic peptidases in enzyme class EC 3.4. Within that class, exopeptidases remove residues or short groups from the ends of peptide chains, whereas endopeptidases cleave internal bonds. Aminopeptidases act at the amino terminus, carboxypeptidases at the carboxyl terminus, and dipeptidyl-peptidases commonly remove two-residue units from an end. These categories describe the position of attack, not a unique catalytic chemistry. The term proteinase has traditionally been associated particularly with endopeptidases acting on proteins, although usage overlaps with protease and peptidase.

A separate classification identifies catalytic types, including serine, cysteine, threonine, aspartic, glutamic, and metalloproteases. The MEROPS database organizes peptidases into families based on sequence relationships and into clans based on evidence of deeper evolutionary relationships, including structural similarity. A family therefore expresses ancestry more directly than a functional label such as “digestive protease.” Conversely, enzymes with similar biological roles may belong to unrelated families. Some modern peptidase classifications also include specialized enzymes, such as asparagine peptide lyases, whose cleavage chemistry is not ordinary hydrolysis; this is one reason that classification by biological activity and classification by reaction mechanism do not coincide perfectly.

Catalytic mechanisms

An uncatalyzed peptide bond is relatively resistant to hydrolysis under ordinary cellular conditions. Its amide group is stabilized by electron delocalization, and its carbonyl carbon is not readily attacked by water. Proteases accelerate cleavage by positioning reactants, activating a nucleophile, transferring protons, and stabilizing high-energy intermediates or transition states. Like other catalysts, they lower the activation barrier without changing the equilibrium position of the overall reaction. A simplified representation is

R1−CO−NH−R2+H2O⟶R1−COOH+H2N−R2.\mathrm{R^1{-}CO{-}NH{-}R^2 + H_2O \longrightarrow R^1{-}COOH + H_2N{-}R^2}.

The actual protonation states of the products depend on pH.

In many serine proteases, a serine side chain supplies the attacking oxygen atom. Chymotrypsin provides the classical example: serine, histidine, and aspartate form a catalytic triad. Histidine facilitates proton transfer, while aspartate helps organize and tune the histidine. The activated serine attacks the substrate carbonyl, producing a tetrahedral intermediate stabilized by an oxyanion hole. Collapse of this intermediate cleaves the peptide bond and leaves an acyl group covalently attached to the enzyme. Water then attacks this acyl-enzyme intermediate, releasing the second product and regenerating the serine. Subtilisin uses a comparable catalytic arrangement despite having a different overall fold, a prominent example of convergent evolution.

Cysteine proteases, including papain and many cathepsins, use a cysteine sulfur atom as the nucleophile, commonly assisted by histidine. They generally form a covalent thioacyl-enzyme intermediate. Threonine proteases use the hydroxyl group of threonine; in the catalytic subunits of the proteasome, this is an amino-terminal threonine whose terminal amino group also contributes to catalysis. These mechanisms share covalent enzyme–substrate chemistry but differ in residue arrangement, proton-transfer pathways, and susceptibility to inhibitors. Mechanistic labels do not imply that every member has an identical catalytic triad or reaction sequence.

Other major classes activate water directly rather than forming a covalent acyl-enzyme intermediate. Aspartic proteases, such as pepsin and HIV protease, typically use two catalytic aspartates to organize water and facilitate proton transfers. Metalloproteases commonly use zinc, although other metals occur. The metal ion helps position and activate water and stabilize charge during cleavage, while a nearby residue often serves as a general acid or base. Thermolysin and many matrix metalloproteinases use this general strategy. Catalytic residues can be supplied by one polypeptide or assembled across subunits, as in the dimeric HIV protease.

Substrate recognition and cleavage specificity

A protease must recognize more than a chemically cleavable bond: almost every protein contains many such bonds. Specificity depends on interactions between the enzyme and residues surrounding the prospective cleavage site, together with the accessibility and shape of the substrate. In the nomenclature introduced by Israel Schechter and Arieh Berger in 1967, substrate residues are designated P1,P2,P3P_1, P_2, P_3, and so forth on the amino-terminal side of the cleaved bond, and P1′,P2′,P3′P_1', P_2', P_3' on the carboxyl-terminal side. Corresponding enzyme-binding regions are called S1,S2S_1, S_2, and S1′S_1', for example. Cleavage occurs between P1P_1 and P1′P_1'.

Trypsin, chymotrypsin, and elastase illustrate how related structures can acquire different preferences. Trypsin generally favors cleavage after lysine or arginine because its primary specificity pocket accommodates their positively charged side chains. Chymotrypsin favors bulky hydrophobic residues, especially aromatic side chains. Pancreatic elastase has a more restricted pocket that favors smaller residues. These preferences are not absolute sequence rules: neighboring residues, substrate conformation, chemical modifications, and reaction conditions affect cleavage. A short peptide that is readily cleaved in solution may therefore fail to predict the processing of the same sequence inside a folded protein.

Interactions outside the catalytic cleft can dominate physiological specificity. Such auxiliary binding regions, often called exosites, allow a protease to recognize a larger substrate surface or an associated molecule. Thrombin has exosites that bind substrates and cofactors, helping distinguish among its roles in coagulation and signaling. Collagen-degrading enzymes face an additional structural problem because the triple helix of collagen restricts access to individual peptide chains. Their substrate-binding and accessory domains help engage and locally destabilize this structure. Similarly, some proteases require a free peptide terminus, a partially unfolded chain, or recruitment by another protein before productive cleavage can occur.

Proteases operating within the cell membrane encounter a further constraint: hydrolysis requires water, yet the substrate bond may lie within a hydrophobic transmembrane segment. Rhomboid proteases and intramembrane metalloproteases create hydrated catalytic environments inside the membrane. Their substrates must enter appropriately positioned access routes, and local helix flexibility can influence cleavage. Consequently, specificity is better understood as a hierarchy of recognition events than as a list of preferred amino acids. Localization, recruitment, conformational access, binding orientation, and catalytic compatibility jointly determine which bonds are actually cut in a living cell.

Activation, inhibition, and spatial control

Proteolysis is often effectively irreversible on the timescale of cellular regulation. Once a protein has been cut, ordinary changes in enzyme activity cannot simply restore the original chain. Cells therefore control proteases at several levels: synthesis, trafficking, activation, assembly, degradation, and inhibition. A common arrangement is production as an inactive precursor, or zymogen. Its additional peptide segment can block the active site, prevent formation of a productive structure, or assist folding before being removed. Activation may require cleavage by another protease, self-processing under suitable conditions, or a change in molecular assembly.

Digestive proteases demonstrate how zymogen activation can be organized into a cascade. The pancreas secretes trypsinogen rather than fully active trypsin. In the small intestine, enteropeptidase initiates its conversion to trypsin, which can activate additional trypsinogen and other pancreatic zymogens. The activation peptide is not merely a removable cap: its cleavage permits structural rearrangements that establish the active catalytic configuration. Similar principles operate in blood coagulation, where sequential protease activation provides amplification. Such cascades are constrained by inhibitors, surface requirements, and competing regulatory reactions, rather than functioning as unrestricted chains of activation.

Endogenous inhibitors provide another major control system. Serpins, including antithrombin and alpha-1 antitrypsin, commonly trap target proteases through cleavage of an exposed reactive loop followed by a large conformational change. Cystatins inhibit many papain-like cysteine proteases by binding across the substrate-binding cleft. Tissue inhibitors of metalloproteinases regulate many extracellular metalloproteases, while alpha-2-macroglobulin can capture a broad range of proteases after they cleave its bait region. These inhibitors differ in reversibility, stoichiometry, and whether they block access directly or sequester the enzyme within a larger molecular enclosure.

Compartmentalization separates proteases from potential substrates. Many digestive enzymes act outside cells, while numerous intracellular hydrolases are concentrated in the lysosome, whose acidic interior supports the activity of several cathepsins. Other proteases are confined to organelles, membrane complexes, or particular cellular surfaces. Calcium concentration can regulate calpains, and assembly into activation platforms controls several inflammatory or apoptotic proteases. Protease activity therefore cannot be inferred reliably from the amount of enzyme protein alone. An abundant precursor may remain inactive, whereas a small, localized pool of active enzyme may produce a substantial biological effect.

Digestion, protein turnover, and cellular processing

In animal digestion, proteases convert dietary proteins into smaller peptides and amino acids that can be absorbed. Gastric pepsin begins substantial protein cleavage in the acidic stomach. Pancreatic endopeptidases, including trypsin, chymotrypsin, and elastase, act in the small intestine, while pancreatic carboxypeptidases remove residues from peptide ends. Enzymes at the intestinal brush border and within intestinal cells complete much of the remaining processing. Different digestive enzymes have overlapping but distinct specificities, allowing a mixture of dietary proteins to be degraded efficiently without requiring one protease capable of cleaving every bond.

Inside cells, selective protein degradation supports quality control and regulates protein abundance. The proteasome is central to one major pathway. In eukaryotic cells, proteins are often marked with chains of ubiquitin, recognized by the regulatory machinery of the 26S proteasome, unfolded using energy from ATP, and translocated into its proteolytic core. Catalytic sites are enclosed within this core, limiting indiscriminate access by folded cellular proteins. The resulting peptides undergo further degradation or enter other pathways. By removing specific regulatory proteins, proteasomal degradation also helps govern the cell cycle and responses to environmental signals.

A complementary pathway delivers cellular material to lysosomes through autophagy or uptake from outside the cell. Lysosomal proteases degrade proteins from damaged organelles, internalized particles, and extracellular material. In mitochondria, specialized proteases and ATP-dependent proteolytic complexes maintain organelle protein quality, process imported proteins, and help regulate mitochondrial organization. Bacteria also possess compartmentalized or chamber-like degradation machines, including Clp and Lon systems. Across these examples, energy-dependent recognition and unfolding frequently determine which substrate reaches the catalytic machinery, while peptide-bond hydrolysis itself does not directly require ATP.

Proteolysis also constructs mature proteins rather than destroying them. Signal peptidases remove targeting sequences from proteins entering secretory pathways. Other processing enzymes convert hormone precursors into active products; proinsulin, for example, undergoes cleavage and further trimming during insulin maturation. Some proteases release membrane-bound regulatory domains so that they can move to another cellular location and alter gene expression. Amino-terminal processing, removal of transit peptides, and cleavage of polyproteins similarly help establish functional proteins. The distinction between degradation and maturation thus depends on the fate of the products: extensive cleavage recycles a chain, whereas limited cleavage can create a stable, specifically active molecule.

Coagulation, immunity, and tissue remodeling

Blood coagulation depends on a network of regulated proteases that couples vessel injury to formation of a localized clot. Several coagulation factors circulate as zymogens and become active serine proteases after limited cleavage. Assembly with cofactors on suitable membrane surfaces greatly accelerates key reactions. Thrombin cleaves fibrinogen to generate fibrin, which polymerizes into the structural network of a clot, and activates other components that reinforce coagulation. The opposing fibrinolytic system uses plasmin to degrade fibrin. Normal clot formation therefore reflects spatially controlled production and removal of a protein scaffold, rather than protease activation alone.

The complement system uses proteolytic cascades in immune defense. Cleavage generates products with different roles: some promote inflammation, some coat targets for recognition, and others contribute to membrane attack. Proteolysis also supports adaptive immunity by generating peptides for presentation through the major histocompatibility complex. Proteasomes contribute many peptides presented by class I molecules, whereas endosomal and lysosomal proteases participate in processing material for class II presentation. Enzymatic trimming can both create and destroy potential epitopes, so antigen presentation depends on the balance among peptide production, transport, binding, and further degradation.

Caspases are cysteine proteases with a characteristic preference for cleavage after aspartate residues. During apoptosis, initiator caspases are activated on molecular platforms and activate executioner caspases. The latter cleave selected structural and regulatory proteins, producing coordinated changes in cellular architecture and function. Other caspases participate in inflammatory signaling and inflammatory cell death. The related functions are not interchangeable: distinct caspases have different activation mechanisms and substrate sets. Immune cells also use granzymes, proteases delivered through pathways associated with perforin, to induce death in target cells.

Outside cells, regulated proteolysis reshapes the extracellular matrix during development, tissue repair, and normal turnover. Matrix metalloproteinases and other extracellular proteases act on matrix proteins, adhesion molecules, and signaling precursors. Their effects extend beyond physically removing tissue: cleavage can expose binding sites, release matrix-associated signals, or generate fragments with biological activities of their own. Protease-activated receptors provide a particularly direct signaling mechanism. Cleavage of their extracellular amino terminus exposes a tethered ligand that activates the receptor. The biological outcome depends on the enzyme, cleavage site, receptor context, and surrounding regulatory network.

Evolution, microorganisms, and ecological roles

Proteolysis is ancient, but the ability to cleave peptide bonds has evolved through multiple structural solutions. Closely related proteases can diverge toward different substrates, while unrelated proteins can converge on similar catalytic arrangements. The resemblance between the catalytic machinery of chymotrypsin-like proteases and subtilisins illustrates convergence rather than close ancestry. Gene duplication and subsequent changes in binding pockets, regulatory segments, or accessory domains have repeatedly expanded protease functions. Some descendants lose essential catalytic residues and become noncatalytic homologues, retaining roles in binding, regulation, or molecular assembly.

Microorganisms use extracellular proteases to gain access to nitrogen and carbon contained in environmental proteins. Large proteins generally cannot cross cell membranes directly, so secreted or surface-associated enzymes break them into peptides and amino acids that transport systems can import. This process is important in soils, sediments, aquatic environments, and decaying organic matter. Enzyme activity depends not only on enzyme production but also on substrate accessibility, adsorption to particles, pH, and temperature. A protease attached to a mineral surface or embedded in a microbial community may behave differently from the purified enzyme in solution.

In bacteria and fungi, proteases also influence competition, development, and interactions with hosts. They may process extracellular signaling molecules, modify cell-surface proteins, contribute to biofilm remodeling, or degrade competing organisms’ proteins. Some pathogenic microorganisms secrete proteases that disrupt host barriers or cleave immune components. Others depend on proteases for maturation of their own exported proteins. Such activities are highly specific to the organism and infection context; the presence of a protease gene alone does not establish a role in disease, because related enzymes frequently perform ordinary nutritional or maintenance functions.

Many viruses encode proteases because they synthesize long polyproteins that must be cut into functional components. HIV produces an aspartic protease required for maturation of viral structural and enzymatic proteins. Coronaviruses encode proteases that process their replicase polyproteins, generating proteins needed for replication and associated functions. These enzymes are often active only after particular assembly or processing steps, linking proteolysis to the timing of the viral life cycle. In plants, proteases mobilize storage proteins during germination, remove damaged proteins, and participate in defense. Papain from papaya and bromelain preparations from pineapple are familiar plant-derived examples, although their commercial names can refer to mixtures rather than a single molecular species.

Proteases in disease and pharmacology

Disease can result from excessive proteolysis, insufficient proteolysis, abnormal localization, or failure to process a particular substrate. The consequences depend on the pathway involved. Alpha-1 antitrypsin deficiency illustrates defective protection against a normally useful protease: reduced effective inhibition of neutrophil elastase contributes to susceptibility to lung tissue damage. Some variants also promote accumulation of abnormal alpha-1 antitrypsin in liver cells, a distinct mechanism from uninhibited elastase activity. In hereditary pancreatitis, certain genetic changes affecting trypsin-related pathways disturb the balance among activation, inhibition, and degradation within the pancreas.

Disorders of clotting demonstrate the importance of both enzyme abundance and molecular assembly. Hemophilia A and B involve deficiencies of coagulation factors VIII and IX, respectively. Factor VIII is a cofactor rather than a protease, whereas activated factor IX is a protease; both are needed for efficient operation of the same reaction complex. Conversely, excessive or misplaced coagulation contributes to thrombosis. Inflammatory and malignant tissues can also exhibit altered protease activity, but individual proteases may have different effects at different stages or sites. Increased expression does not by itself establish that inhibiting the enzyme will improve disease.

Proteases are established drug targets because their catalytic sites provide defined molecular binding environments. HIV protease inhibitors entered clinical use in the 1990s and became important components of combination antiretroviral therapy. Inhibitors of hepatitis C virus NS3/4A protease form another antiviral class. Nirmatrelvir targets the main protease of SARS-CoV-2. Outside virology, angiotensin-converting enzyme inhibitors act on a zinc-dependent peptidase involved in production and degradation of vasoactive peptides, while direct inhibitors of thrombin or factor Xa reduce coagulation. These examples involve different catalytic classes and physiological pathways rather than a common therapeutic effect of “protease inhibition.”

Selectivity is a central pharmacological problem. Related proteases can have similar active sites, and an inhibitor may affect several host enzymes even if it binds its intended target strongly. Drugs can exploit substrate-binding pockets, covalent interactions with catalytic residues, allosteric sites, or structural features of a particular enzyme complex. Protease inhibitors may be reversible or irreversible, and covalent binding need not be irreversible. Resistance can arise through changes in a target protease or in interacting viral proteins. Some therapies instead use proteolysis directly: tissue plasminogen activator promotes conversion of plasminogen to plasmin, while pancreatic enzyme preparations replace deficient digestive activity.

Experimental measurement and substrate discovery

Protease activity is commonly measured by following the disappearance of a substrate or appearance of a cleavage product. Early assays used proteins such as casein or gelatin and quantified soluble fragments or loss of an intact substrate. Modern assays often employ synthetic peptides carrying chromogenic or fluorescent groups. Cleavage can release a colored product or separate a fluorophore from a quencher, allowing activity to be monitored continuously. These approaches are sensitive and convenient, but a short reporter peptide usually measures cleavage under defined laboratory conditions rather than the full substrate selection occurring inside a cell.

For a simple enzyme–substrate system, initial rates may be described by Michaelis–Menten kinetics:

v0=kcat[E]T[S]Km+[S].v_0=\frac{k_{\mathrm{cat}}[E]_{\mathrm{T}}[S]}{K_m+[S]}.

Here, v0v_0 is the initial reaction rate, kcatk_{\mathrm{cat}} is the turnover number, [E]T[E]_{\mathrm{T}} is the concentration of active enzyme, [S][S] is substrate concentration, and KmK_m is the Michaelis constant. The ratio kcat/Kmk_{\mathrm{cat}}/K_m describes catalytic efficiency in the low-substrate limit for this model. Importantly, KmK_m is not generally identical to a substrate dissociation constant. Interpretation becomes more complicated when substrates aggregate, enzymes require activation, products inhibit the reaction, or multiple cleavage events occur.

Activity-based probes can identify catalytically active proteases rather than merely detecting their abundance. Such probes typically combine a recognition element, a reactive group, and a detectable tag. Appropriate controls are necessary because reaction with an accessible nucleophile does not automatically establish selective labeling of the intended enzyme. In-gel zymography provides another approach: substrates incorporated into a gel reveal zones of proteolysis after proteins are separated and incubated under activity-supporting conditions. However, electrophoresis and subsequent renaturation can alter enzyme complexes and inhibitor interactions, so the resulting bands do not directly reproduce activity in the original sample.

Identifying physiological substrates requires complementary evidence. Mass spectrometry and proteomics can detect cleavage products and map newly generated protein termini, an approach often called terminomics. Genetic perturbation, inhibitor treatment, cleavage-site mutation, and purified-component experiments help distinguish direct substrates from downstream effects. Structural methods reveal how substrates or inhibitors occupy an active site, while cellular imaging can show where cleavage occurs. A persuasive assignment generally connects biochemical cleavage with appropriate localization and a demonstrable biological consequence. Merely finding that a purified enzyme can cut a protein at high concentration is insufficient to establish that the reaction normally occurs in an organism.

Industrial and laboratory applications

Proteases are widely used industrial enzymes because proteins occur in many raw materials and products. Microbial fermentation, particularly using selected bacterial and fungal strains, permits production at large scale. Commercial performance depends on more than catalytic rate: an enzyme must survive manufacturing, storage, and the chemical environment of its intended process. Protein engineering and strain improvement can alter stability, substrate preference, secretion yield, and resistance to oxidation or self-digestion. Formulation may also separate the enzyme from incompatible ingredients until use. The optimum enzyme for one process may be unsuitable for another because their pH, temperature, and substrate requirements differ.

In laundry and cleaning products, proteases break down protein-containing deposits such as food residues and blood-derived stains. Many detergent proteases are subtilisin-related enzymes selected or engineered for activity under alkaline conditions and compatibility with surfactants. Stability in the presence of oxidants, chelators, and other formulation components is important. Lower-temperature washing creates additional demands because adequate activity must be retained without relying on heat. Industrial handling also addresses the capacity of airborne enzyme proteins to cause respiratory sensitization, using containment and formulations that reduce dust or aerosol exposure.

Food processing uses proteolysis both to change texture and to generate defined products. Chymosin cleaves bovine kappa-casein at a specific bond, destabilizing casein micelles and enabling coagulation in cheese production. Commercial chymosin may be obtained through fermentation using recombinant microorganisms. Other proteases produce protein hydrolysates, alter dough properties, tenderize meat, or modify the solubility and functional properties of food proteins. Control is crucial: excessive cleavage can destroy texture or produce bitterness through the release of particular peptides. Leather processing likewise uses proteases in operations that remove or modify unwanted protein components, although process conditions must protect the material’s desired structural properties.

In research laboratories, trypsin is a standard reagent for preparing proteins for mass-spectrometric analysis because its cleavage preferences generate peptides that are often suitable for separation and identification. Engineered fusion proteins can carry recognition sequences for proteases such as tobacco etch virus protease, allowing purification tags to be removed after isolation. Proteinase K is used in many nucleic-acid preparation workflows to digest proteins, including nucleases that could damage the sample. Limited proteolysis can reveal exposed or flexible regions of a protein, and protease protection assays help establish whether a protein segment is accessible on a particular side of a membrane. In each application, cleavage conditions are chosen to exploit a defined structural or biochemical property rather than indiscriminate protein destruction.